查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1450999

2024-2032 年按產品、應用、配方和地區分類的止血劑市場報告

Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球止血劑市場規模達到35億美元。展望未來， IMARC Group預計到2032年市場規模將達到58億美元，2024-2032年複合年成長率（CAGR）為5.73%。外科手術的增加、技術的進步、醫療基礎設施的擴張、醫療保健專業人員意識的提高以及人口老化的加劇是推動市場的一些主要因素。

止血鉗是指在外科手術或傷口治療期間透過夾緊血管或組織來控制出血的醫療器械。它們通常由一對鉸接的剪刀狀手柄組成，工作端帶有鋸齒狀鉗口。當擠壓手柄時，鉗口閉合，牢牢抓住組織或血管。這可以防止血液流動並有利於精確操作或縫合。止血劑有各種尺寸和設計，使其成為醫療保健環境中的多功能工具。它們在確保手術場無血、降低失血過多的風險以及實現有效的醫療程序方面發揮著至關重要的作用。

外科手術（包括複雜手術、微創手術和創傷病例）發生率的上升是推動止血劑和器械需求的主要因素。此外，隨著全球人口持續老化，心血管疾病和癌症等需要手術介入的慢性疾病的盛行率不斷增加，有助於市場擴張。同時，醫療技術的不斷進步促進了創新止血產品的開發，其功效和安全性得到提高，進一步推動了市場成長。此外，醫療保健專業人員越來越意識到有效止血對於減少併發症和改善患者預後的重要性，這推動了止血劑的採用。此外，隨著外科護理的普及，新興市場醫療保健基礎設施的擴張，加上醫療保健支出的增加，正在促進止血劑市場的成長。

止血劑市場趨勢/促進因素：

增加外科手術

全球外科手術數量的不斷增加是止血劑市場的重要動力。手術介入對於治療各種疾病至關重要，從闌尾切除術等常規手術到器官移植等複雜手術。隨著全球人口持續成長和老化，心血管疾病、癌症和骨科問題等慢性疾病的盛行率也在上升。這導致對外科手術以及止血劑和器械的需求不斷增加。止血劑在這些手術中對於控制出血、降低併發症風險和改善患者預後至關重要。

持續的技術進步

醫療技術的進步在止血劑市場的成長中發揮了關鍵作用。這些創新促進了更有效、更安全的止血產品的開發。例如，新型止血劑通常採用生物相容性和生物可吸收材料，降低不良反應的風險。此外，一些止血劑的作用速度更快，從而節省了寶貴的手術時間。此外，微創手術等外科技術的進步增加了對這些手術量身定做的專用止血工具的需求。技術創新持續推動產品開發，提升整體市場。

新興市場的醫療基礎設施擴張

新興市場，特別是亞洲、拉丁美洲和非洲，醫療基礎設施和支出正在經歷顯著成長。這種擴張是由城市化、可支配收入增加以及政府為改善醫療保健所採取的更多措施所推動的。隨著醫療保健設施變得更加便利，在這些地區進行的外科手術數量正在增加。因此，對支持這些手術的止血劑和儀器的需求不斷成長。醫療保健基礎設施的擴張不僅擴大了市場的地理範圍，而且還促進了本地和國際止血劑製造商之間的夥伴關係和合作機會。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球止血劑市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 基於凝血酶
    • 市場走向
    • 市場預測
  • 基於組合
    • 市場走向
    • 市場預測
  • 氧化再生纖維素基
    • 市場走向
    • 市場預測
  • 明膠基
    • 市場走向
    • 市場預測
  • 基於膠原蛋白
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 骨科手術
    • 市場走向
    • 市場預測
  • 一般外科
    • 市場走向
    • 市場預測
  • 神經外科
    • 市場走向
    • 市場預測
  • 心血管外科
    • 市場走向
    • 市場預測
  • 重建手術
    • 市場走向
    • 市場預測
  • 婦科手術
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配方

  • 基質止血劑和凝膠止血劑
    • 市場走向
    • 市場預測
  • 止血片和止血墊
    • 市場走向
    • 市場預測
  • 海綿止血鉗
    • 市場走向
    • 市場預測
  • 粉末止血劑
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Arch Therapeutics Inc.
    • Baxter International Inc.
    • B. Braun Melsungen Aktiengesell
    • CR Bard Inc. (BD)
    • GELITA MEDICAL GmbH
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Pfizer Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Z-Medica LLC
Product Code: SR112024A2381

The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032. The rising surgical procedures, technological advancements, expansion of healthcare infrastructure, increasing awareness among healthcare professionals, and a growing aging population are some of the major factors propelling the market.

The rising incidence of surgical procedures, including complex surgeries, minimally invasive procedures, and trauma cases, represents the prime factor fueling the demand for hemostatic agents and instruments. Moreover, as the global population continues to age, the prevalence of chronic diseases necessitating surgical interventions, such as cardiovascular diseases and cancer, is increasing, aiding in market expansion. Concurrent with this, ongoing advancements in medical technology have led to the development of innovative hemostatic products with improved efficacy and safety profiles, further propelling market growth. Additionally, the growing awareness among healthcare professionals about the importance of effective hemostasis to reduce complications and enhance patient outcomes has driven the adoption of hemostats. Furthermore, the expansion of healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure, is contributing to the growth of the hemostats market as access to surgical care becomes more widespread.

Hemostats Market Trends/Drivers:

Increasing surgical procedures

The growing number of surgical procedures worldwide is a significant driver for the hemostats market. Surgical interventions are essential for treating various medical conditions, from routine procedures like appendectomies to complex surgeries like organ transplants. As the global population continues to grow and age, the prevalence of chronic diseases such as cardiovascular diseases, cancer, and orthopedic issues is also on the rise. This has led to an increasing demand for surgical interventions, and consequently, hemostatic agents and instruments. Hemostats are crucial in these procedures to control bleeding, reduce the risk of complications, and improve patient outcomes.

Ongoing technological advancements

Advances in medical technology have played a pivotal role in the growth of the hemostats market. These innovations have led to the development of more effective and safer hemostatic products. For example, newer hemostats often incorporate biocompatible and bioabsorbable materials, reducing the risk of adverse reactions. Additionally, some hemostatic agents are engineered to work more rapidly, thus saving valuable surgical time. Moreover, advancements in surgical techniques, such as minimally invasive surgery, have increased the demand for specialized hemostatic tools tailored to these procedures. Technological innovations continue to drive product development, enhancing the overall market.

Healthcare infrastructure expansion in emerging markets

Emerging markets, particularly in Asia, Latin America, and Africa, are experiencing significant growth in healthcare infrastructure and expenditure. This expansion is driven by urbanization, rising disposable incomes, and increased government initiatives to improve healthcare access. As healthcare facilities become more accessible, the number of surgical procedures performed in these regions is on the rise. Consequently, there is a growing demand for hemostatic agents and instruments to support these surgeries. The expansion of healthcare infrastructure not only increases the market's geographical reach but also fosters opportunities for partnerships and collaborations between local and international hemostat manufacturers.

Hemostats Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hemostats market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and formulation.

Breakup by Product:

Thrombin Based

Combination Based

Oxidized Regenerated Cellulose Based

Gelatin Based

Collagen Based

Thrombin based dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes thrombin based, combination based, oxidized regenerated cellulose based, gelatin based, and collagen based. According to the report, thrombin based represented the largest segment.

The demand for thrombin based hemostats is being propelled by their rapid action and versatility in managing bleeding in various medical scenarios. Thrombin is a naturally occurring enzyme that plays a crucial role in the blood clotting process. Thrombin-based hemostats offer a targeted and rapid solution for achieving hemostasis, making them particularly valuable in situations where time is critical, such as emergency surgeries and trauma cases. Furthermore, their ability to work independently of the body's clotting mechanisms makes them an attractive option, and their compatibility with other hemostatic agents enhances their versatility in surgical applications, further driving their demand in the healthcare industry.

Breakup by Application:

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Reconstructive Surgery

Gynecological Surgery

Others

General surgery holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes orthopedic, general, neurological, cardiovascular, reconstructive, gynecological, and other surgeries. According to the report, general surgery accounted for the largest market share.

The increasing complexity and diversity of surgical procedures represent one of the main factors impelling the need for hemostats in general surgery applications. General surgery encompasses a wide range of operations, from abdominal surgeries to vascular procedures, each posing unique challenges in achieving effective hemostasis. Surgeons are increasingly relying on hemostatic agents and instruments to minimize bleeding, reduce operating time, and enhance patient outcomes. As surgical techniques advance, minimally invasive procedures become more common, necessitating specialized hemostatic tools. Moreover, the expanding aging population with comorbidities requires more surgical interventions, further fueling the demand for reliable and versatile hemostats in general surgery applications.

Breakup by Formulation:

Matrix and Gel Hemostats

Sheet and Pad Hemostats

Sponge Hemostats

Powder Hemostats

Matrix and gel hemostats dominate the market

The report has provided a detailed breakup and analysis of the market based on the formulation. This includes matrix and gel, sheet and pad, sponge, and powder hemostats. According to the report, matrix and gel hemostats represented the largest segment.

The demand for matrix and gel hemostats is driven by their unique characteristics, such as ease of application and versatility in various medical settings. These hemostatic products offer a user-friendly approach to achieving hemostasis, especially in situations where precise control is essential, such as neurosurgery and ophthalmic procedures. Matrix and gel hemostats conform to irregular wound shapes and adhere well to tissues, ensuring effective sealing of bleeding sites. Apart from this, they often have a resorbable nature, reducing the risk of adverse reactions and minimizing the need for postoperative removal, making them increasingly favored by surgeons and healthcare professionals in diverse clinical applications.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest hemostats market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American hemostats market is experiencing significant growth due to the region's aging population driving a higher prevalence of chronic diseases, resulting in an increased demand for surgical interventions, which in turn necessitates the use of hemostatic agents and instruments. Concurrent with this, the well-established healthcare infrastructure in North America, coupled with high healthcare expenditure, allows for extensive adoption of advanced hemostatic technologies and products. Additionally, ongoing technological advancements in the healthcare sector, particularly in the United States, are contributing to the development of innovative hemostatic solutions that are highly sought after by healthcare providers. Furthermore, the region's regulatory environment and stringent quality standards ensure the availability of safe and effective hemostats, further boosting market growth. Apart from this, the rising awareness among healthcare professionals regarding the importance of efficient hemostasis to minimize complications is propelling the North America hemostats market forward.

Competitive Landscape:

The global hemostats market is characterized by intense competition, driven by a multitude of established and emerging players striving to gain a competitive edge. Key market participants include leading healthcare companies that have a strong global presence and offer a wide range of hemostatic products. These industry giants engage in extensive research and development efforts to introduce innovative hemostats and expand their product portfolios. Additionally, smaller, niche-focused companies are gaining prominence by offering specialized hemostatic solutions. Collaborations, partnerships, and mergers and acquisitions are common strategies in this dynamic landscape, aimed at strengthening market positions and enhancing product offerings. The competitive rivalry is further fueled by the increasing demand for minimally invasive surgery and the ongoing quest to develop hemostatic agents with enhanced safety profiles, driving continuous innovation and competitiveness in the global hemostats market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Arch Therapeutics Inc.

Baxter International Inc.

B. Braun Melsungen Aktiengesell

C. R. Bard Inc.

GELITA MEDICAL GmbH

Integra LifeSciences Corporation

Johnson & Johnson

Pfizer Inc.

Stryker Corporation

Teleflex Incorporated

Z-Medica LLC

Recent Developments:

In July 2023, Baxter International Inc. announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.

In April 2023, Arch Therapeutics, Inc. a marketer and developer of novel self-assembling wound care and biosurgical products, unveiled its AC5(R) Advanced Wound System ("AC5") at the Symposium on Advanced Wound Care. .

Key Questions Answered in This Report:

  • How has the global hemostats market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hemostats market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the formulation?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hemostats market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemostats Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Thrombin Based
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Based
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidized Regenerated Cellulose Based
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gelatin Based
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Collagen Based
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Orthopedic Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 General Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Surgery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Surgery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Reconstructive Surgery
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Gynecological Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Formulation

  • 8.1 Matrix and Gel Hemostats
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sheet and Pad Hemostats
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Sponge Hemostats
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Powder Hemostats
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arch Therapeutics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 B. Braun Melsungen Aktiengesell
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 C. R. Bard Inc. (BD)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 GELITA MEDICAL GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Integra LifeSciences Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Z-Medica LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Hemostats Market: Major Drivers and Challenges
  • Figure 2: Global: Hemostats Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hemostats Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Hemostats Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Hemostats Market: Breakup by Formulation (in %), 2023
  • Figure 6: Global: Hemostats Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Hemostats Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Hemostats Market (Thrombin Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Hemostats Market Forecast (Thrombin Based): Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Hemostats Market (Combination Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hemostats Market Forecast (Combination Based): Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hemostats Market (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hemostats Market Forecast (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hemostats Market (Gelatin Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hemostats Market Forecast (Gelatin Based): Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hemostats Market (Collagen Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hemostats Market Forecast (Collagen Based): Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hemostats Market (Orthopedic Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hemostats Market Forecast (Orthopedic Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hemostats Market (General Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hemostats Market Forecast (General Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hemostats Market (Neurological Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hemostats Market Forecast (Neurological Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hemostats Market (Cardiovascular Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hemostats Market Forecast (Cardiovascular Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hemostats Market (Reconstructive Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hemostats Market Forecast (Reconstructive Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hemostats Market (Gynecological Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hemostats Market Forecast (Gynecological Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Hemostats Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Hemostats Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Hemostats Market (Matrix and Gel Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Hemostats Market Forecast (Matrix and Gel Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Hemostats Market (Sheet and Pad Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Hemostats Market Forecast (Sheet and Pad Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Hemostats Market (Sponge Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Hemostats Market Forecast (Sponge Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Hemostats Market (Powder Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Hemostats Market Forecast (Powder Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia Pacific: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia Pacific: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Hemostats Industry: SWOT Analysis
  • Figure 89: Global: Hemostats Industry: Value Chain Analysis
  • Figure 90: Global: Hemostats Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hemostats Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Hemostats Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hemostats Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Hemostats Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
  • Table 5: Global: Hemostats Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Hemostats Market Structure
  • Table 7: Global: Hemostats Market: Key Players